Overview
Status
Active
Registry date
2018-08-29
Share capital
5,000.00 PLN
Registered address
ul. Zambrowska 36, 61-051 Poznań, Poland
Financials
This entity has not filed any financial documents with the Financial Document Repository (RDF).
Industry
Authorized Representatives
Andrzej Adam Mackiewicz – President of the Management Board
Jacek Mackiewicz – Management Board Member
Manner of representation
Each member of the management board has the right to represent the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 10 | $135.06 | 10% | |
Andrzej Adam Mackiewiczage 73 | 80 | $1,080.50 | 80% |
Jacek Mackiewiczage 47 | 10 | $135.06 | 10% |
Andrzej Adam Mackiewicz and Jacek Mackiewicz hold a combined 90% – the ownership structure indicates family control.
Beneficial owners
No beneficial owners recorded for the company Inthervax.
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jul 13, 2026 | Dissolution without liquidation opened |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| GenxoneS.A. | $665,361.35 | genxone.eu | ||
| Polbiotech Laboratoriumsp. z o.o. | $645,943.81 | polbiotech.pl | ||
| Explorna Therapeuticssp. z o.o. | $304,662.00 | explorna.com | ||
| Relvosp. z o.o. | $120,693.26 | relvo.pl | ||
| Microblicsp. z o.o. | $122,383.50 | microblic.pl | ||
| Xenstatssp. z o.o. | $66,774.27 | xenstats.com | ||
| Fungotechsp. z o.o. | $187.68 | fungo.tech | ||
| Ncage TherapeuticsS.A. | $29.14 | ncage.org | ||
| Dystrogen TherapeuticsS.A. | – | dystrogen.com | ||
| MIMO BiotechP.S.A. | – | mimobiotech.com |
FAQ
The main business activity of Inthervax focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on August 29, 2018.
The headquarters is located at: ul. Zambrowska 36, 61-051 Poznań.
The management board includes Andrzej Adam Mackiewicz (President of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
Last updated: 2026-04-08